![Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-020-03941-8/MediaObjects/12891_2020_3941_Fig1_HTML.png)
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text
![PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study](https://i1.rgstatic.net/publication/349041855_Low_BASDAI_score_alone_is_not_a_good_predictor_of_anti-tumor_necrosis_factor_treatment_efficacy_in_ankylosing_spondylitis_a_retrospective_cohort_study/links/601d53db299bf1cc26a6b2d8/largepreview.png)
PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study
Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients
Ankylosing spondylitis GIM teaching Cases from routine outpatients……. Case 1 NK 65 yr old builder Sep 2014 Ask about SpA fea
![Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open](https://rmdopen.bmj.com/content/rmdopen/8/1/e001955/F5.large.jpg)
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open
![Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis](https://www.frontiersin.org/files/Articles/856654/fmed-09-856654-HTML/image_m/fmed-09-856654-g001.jpg)
Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
![Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis](https://www.frontiersin.org/files/Articles/856654/fmed-09-856654-HTML/image_m/fmed-09-856654-t002.jpg)
Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
![Article medicale Tunisie, Article medicale Ankylosing spondylitis , Spondylarthropathy , Functional index , BASFI , Disease activity index , BASDAI Article medicale Tunisie, Article medicale Ankylosing spondylitis , Spondylarthropathy , Functional index , BASFI , Disease activity index , BASDAI](https://www.latunisiemedicale.com/userfiles/image/tab2-N10-532-535.jpg)
Article medicale Tunisie, Article medicale Ankylosing spondylitis , Spondylarthropathy , Functional index , BASFI , Disease activity index , BASDAI
![mariajosem on Twitter: "#LOMEJORSPA21 @SEReumatologia @SMurcianaReuma ‼️Arrancamos con el Dr @mjmorenoramos q nos cuenta la novedad clínica en #espondiloartritisaxial 🧵 ✓Cambio de paradigma: evaluar, medir, estudiar ✓ASDAS>BASDAI ✓BASDAS en ... mariajosem on Twitter: "#LOMEJORSPA21 @SEReumatologia @SMurcianaReuma ‼️Arrancamos con el Dr @mjmorenoramos q nos cuenta la novedad clínica en #espondiloartritisaxial 🧵 ✓Cambio de paradigma: evaluar, medir, estudiar ✓ASDAS>BASDAI ✓BASDAS en ...](https://pbs.twimg.com/media/EwS2xoLXAAM6jf1.jpg)
mariajosem on Twitter: "#LOMEJORSPA21 @SEReumatologia @SMurcianaReuma ‼️Arrancamos con el Dr @mjmorenoramos q nos cuenta la novedad clínica en #espondiloartritisaxial 🧵 ✓Cambio de paradigma: evaluar, medir, estudiar ✓ASDAS>BASDAI ✓BASDAS en ...
![Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/1/35/F1.large.jpg)
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology
![Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations | Annals of the Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations | Annals of the](https://ard.bmj.com/content/annrheumdis/68/11/1701/F1.large.jpg)